By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Prima Biomed 

Unit 7, 79 - 83 High Street

Melbourne  Victoria  3101  Australia
Phone: 61-3-9854-5700 Fax: 61-3-9854-5777



Company News
Prima Biomed (PRR.AX) Collaborates In Investigator Sponsored New Clinical Trial For IMP321 In Solid Tumors 7/13/2016 10:59:20 AM
Prima Biomed (PRR.AX) Announces First Safety, Pharmacokinetics And Immuno-Monitoring Data From Phase IIb Clinical Trial Of IMP321 6/22/2016 11:57:59 AM
Prima Biomed (PRR.AX) To Maintain NASDAQ Listing 6/7/2016 9:14:14 AM
Prima Biomed (PRR.AX) Surges on $293 Million License Deal for CVac 5/12/2016 6:04:31 AM
Prima Biomed (PRR.AX) Release: Japanese Patent Grants For IMP321 In Cancer 5/2/2016 11:04:01 AM
Prima Biomed (PRR.AX) Release: IMP321 Safety And Immune Monitoring Data Published In Clinical Cancer Research Journal 3/16/2016 9:46:25 AM
Prima Biomed (PRR.AX) Receives NASDAQ Notice Of Bid Price Deficiency 3/7/2016 1:12:13 PM
Prima Biomed (PRR.AX) And WuXi Biologics Announce First Dose Of Chinese-Manufactured Biologic In EU Clinical Trial 3/2/2016 6:12:27 AM
Prima Biomed (PRR.AX) Release: U.S. Patent Grants For IMP731 Antibody 1/28/2016 11:10:11 AM
Prima Biomed (PRR.AX) Initiates Phase I Melanoma Study In Australia 1/27/2016 10:41:14 AM